Zoetis ZTS
NYSE ZTS
$76.30 -0.38 (-0.50%)
At close: Aug 20, 2026 · 11:59 AM UTC

Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026)

Zoetis (ZTS) posted quarterly Depreciation & Amortization (CF) of $119.0 million for Q1 2026, little changed year-over-year from $119.0 million in Q1 2025, and down 1.65% quarter-over-quarter from $121.0 million in Q4 2025.

Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Depreciation & Amortization (CF) for 15 consecutive years, with $119.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $119.0 million; the TTM figure through Mar 2026 stood at $487.0 million (down 0.61% YoY), while the FY2025 annual figure was $487.0 million, down 2.01% from the prior year.
  • Depreciation & Amortization (CF) fell to $119.0 million in Q1 2026 per ZTS's latest filing, from $121.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $127.0 million in Q2 2024 and bottomed at $114.0 million in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $121.1 million across 5 years, with a median of $121.0 million in 2023.
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) advanced 7.83% — and 2025, when it dropped 5.56%.
  • Zoetis' Depreciation & Amortization (CF) stood at $119.0 million in 2022, then advanced by 5.88% to $126.0 million in 2023, then declined by 2.38% to $123.0 million in 2024, then slipped by 1.63% to $121.0 million in 2025, then declined by 1.65% to $119.0 million in 2026.
  • Business Quant data shows ZTS's Depreciation & Amortization (CF) at $119.0 million in Q1 2026, $121.0 million in Q4 2025, and $124.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn 241.00 Mn
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn -
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - -
10 Alkermes 8.20 Bn 7.55 Bn 397.90 Mn 30.28 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 119.00 Mn
Jun 30, 2026 119.00 Mn
Mar 31, 2026 119.00 Mn
Mar 31, 2026 119.00 Mn
Dec 31, 2025 121.00 Mn
Dec 31, 2025 121.00 Mn
Sep 30, 2025 124.00 Mn
Sep 30, 2025 124.00 Mn
Jun 30, 2025 123.00 Mn
Jun 30, 2025 123.00 Mn
Mar 31, 2025 119.00 Mn
Mar 31, 2025 119.00 Mn
Dec 31, 2024 123.00 Mn
Dec 31, 2024 123.00 Mn
Sep 30, 2024 121.00 Mn
Sep 30, 2024 121.00 Mn
Jun 30, 2024 127.00 Mn
Jun 30, 2024 127.00 Mn
Mar 31, 2024 126.00 Mn
Mar 31, 2024 126.00 Mn